Copper-64: An Optimal Radionuclide for the Routine Preparation of PET Imaging Radiotracers from GMP-Lyophilized Gelatin-NOTA-Peptide Kits
Authors:
- Myrna Luna-GutiérrezMyrna Luna-Gutiérrez
- Erika Azorín-VegaErika Azorín-Vega
- Blanca Ocampo-GarcíaBlanca Ocampo-García
- Nallely Jiménez-MancillaNallely Jiménez-Mancilla
- Clara Santos-CuevasClara Santos-Cuevas
- Nancy Lara-AlmazánNancy Lara-Almazán
- Cintya Herrera-GarcíaCintya Herrera-García
- Laura Meléndez-AlafortLaura Meléndez-Alafort
- Guillermina Ferro-FloresGuillermina Ferro-Flores
Open Access
- 28 May 2026
- journal article
- research article
- Published by MDPI AG in Inorganics
- Vol. 14 (6) , 146
Abstract
Copper-64 is increasingly recognized for its advantages in positron emission tomography (PET) imaging and theranostic applications due to its favorable half-life, decay profile, and high spatial resolution. This research addresses the need for reliable, high-purity PET radiotracers by developing GMP-grade lyophilized kits for one-step preparation of 64Cu-NOTA-peptides using gelatin as a chelating agent for metallic impurities and NOTA for selective copper binding. The approach was applied to five peptide analogs formulated for fast 64Cu labeling: NOTA-iPSMA, NOTA-TOC, NOTA-iPD-L1, NOTA-iFAP, and NOTA-UBI 29–41, which were preclinically evaluated to enable the precise molecular imaging of cancer and infection. Each multidose kit included 0.5 μmol of the NOTA-peptide and 25 mg of gelatin, labeled with 925 MBq of 64Cu. The radiochemical purity of the 64Cu-NOTA-peptides exceeded 98% (mean 99.2% ± 0.3%) without the need for additional purification. The 64Cu-radiotracers remained stable for at least 24 h at room temperature and showed high stability in human serum. In preclinical studies, saturation-binding assays demonstrated that affinity (Kd) was less than 10 nM in all 64Cu-NOTA-peptides, with tumor-to-lung ratios ranging from 14 to 290 at 2 h post-injection and low liver uptake (2.95% ± 1.36% ID/g). The research demonstrated that these formulations, which include peptides specific to PSMA, SSTR2, PD-L1, FAP, and infection sites, offer excellent in vivo performance and high PET imaging quality in mice with induced tumors or infection sites. The findings support the use of gelatin-NOTA-peptide kits as a standardized and practical solution for producing 64Cu-labeled peptides, facilitating routine clinical PET imaging, and advancing personalized molecular diagnostics.Keywords
Funding Information
- Secretary of Science, Humanities, Technology, and Innovation (MADTEC-2025-M-135)
- International Atomic Energy Agency (CRP-F22078)
- International Atomic Energy Agency (MEX6013)
This publication has 31 references indexed in Scilit:
- A series of conjugates based on prostate-specific membrane antigen ligands with the chelating agent DOTA: synthesis, radiolabeling, and biological activityEuropean Journal of Medicinal Chemistry, 2025
- Comparison of 64Cu-DOTA-PSMA-3Q and 64Cu-NOTA-PSMA-3Q utilizing NOTA and DOTA as bifunctional chelators in prostate cancer: preclinical assessment and preliminary clinical PET/CT imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2025
- Assessment of chromatography separation parameters in the quality control of copper-64-labeled neurotensin-like peptidesJournal of Radioanalytical and Nuclear Chemistry, 2024
- Complexes of NOTA‐Monoamides with CuII Ions: Structural, Equilibrium, and Kinetic StudyEuropean Journal of Inorganic Chemistry, 2022
- Synthesis and formulation of [64Cu]Cu-PTSM for PET perfusion imaging in small animal modelsApplied Radiation and Isotopes, 2022
- A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and RetentionAngewandte Chemie International Edition, 2019
- Concentration‐dependent effects of dutasteride on prostate‐specific membrane antigen (PSMA) expression and uptake of 177Lu‐PSMA‐617 in LNCaP cellsThe Prostate, 2019
- Macrocyclic Bifunctional Chelators and Conjugation Strategies for Copper-64 Radiopharmaceuticals2016
- Integral membrane protease fibroblast activation protein sensitizes fibrosarcoma to chemotherapy and alters cell death mechanismsApoptosis, 2015
- Module-assisted preparation of 64Cu with high specific activityApplied Radiation and Isotopes, 2012